Adult Stem Cells Are Helping Scleroderma Patients PDF Print E-mail
Wednesday, 20 July 2011 22:37
Dr. Richard Burt and colleagues at Northwestern University have just published a new study in The Lancet that provides more evidence for the success of adult stem cell transplant in treating System Sclerosis (Scleroderma).

Ten patients were treated with their own adult stem cells, and all improved at or before 12 months after treatment, compared with zero of the nine patients that received cyclophosphamide, a chemotherapeutic agent considered the “standard of care” for this disease. None of the adult stem cell-treated patients had their disease worsen, while 8 of the 9 chemo-treated patients showed worsening, and eventually 7 of the chemo patients switched to the adult stem cell treatment.

The researchers note that the adult stem cell treatment improves skin and lung function in these patients for up to 2 years (the length of the current study) and is preferable to the current standard of care.

The new report is accompanied by a commentary by Farge and Gluckman that says the Burt et al. study provides “the best data to date for transplantation in Scleroderma”, and “Despite the small number of patients and short follow-up of ASSIST, the findings of this trial are important for patients with systemic sclerosis, the medical community, and policy makers.”

Dr. Burt is featured in a recently-released video discussing his ideas for use of adult stem cells to treat patients with autoimmune diseases. Burt and his team are using this technique to help treat patients suffering from some 23 different diseases, and the techniques he has developed are now being used in treatment centers around the globe.

Adult stem cells are helping patients now.

Source: Prentice, D. (2011), "Adult Stem Cells Helping Patients With Scleroderma Skin Disease"; Lifenews.com; original article can be viewed here.

 
More articles :

» A New Marker of Silent Cardiovascular Disease in Diffuse Scleroderma

Patients with diffuse systemic sclerosis (SSc) and no clinical evidence of (CVD) may, in fact, have subclinical CVD and , and it is detectable. This is the conclusion of a small pilot study from Italy, which showed that elevated plasma levels of ...

» Donating Kidney Doesn't Shorten Lifespan

A study of over 80,000 American live kidney donors found they were likely to live just as long as people who have two healthy kidneys and that the procedure carries very little medical risk.You can read about the by lead author and transplant...

» Scleroderma Drug In Development

According to , has partnered with , the health care investment arm of Morgan Keegan and Co. Inc., to jump-start a capital campaign to raise $12 million to $15 million. ArGentis shelved the campaign last year when the economy soured.The money will...

» Novel Pharmaceutical Treatment for Scleroderma Discovered

A novel pharmaceutical treatment for scleroderma, comprising the administration of miR-29, has been discovered by Steffen Gay, Oliver Distler and Britta Maurer of the Department of Rheumatology at Zurich University. Scleroderma is a chronic...

» Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate in Severe Localized Scleroderma

Alexander Kreuter, MD; Thilo Gambichler, MD; Frank Breuckmann, MD; Sebastian Rotterdam, MD; Marcus Freitag, MD; Markus Stuecker, MD; Klaus Hoffmann, MD; Peter Altmeyer, MDArch Dermatol. 2005;141:847-852Objective: To evaluate the efficacy of pulsed...

» Scleroderma May Be Initated By Cancer

has reported that researchers at have discovered that some cases of are likely to have been initiated by Cancer.  In a landmark paper published in Science, researchers focusing on a select group of patients with both Scleroderma and Cancer,...